Tvardi Therapeutics Ownership | Who Owns Tvardi Therapeutics?

Tvardi Therapeutics Ownership Summary

Tvardi Therapeutics is owned by 19.53% institutional investors, 27.53% insiders, and 52.94% retail investors. Slate path capital lp is the largest institutional shareholder, holding 8.54% of TVRD shares.

TVRD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Tvardi Therapeutics	19.53%	27.53%	52.94%
Sector	Healthcare Stocks	232.51%	10.72%	-143.22%
Industry	Biotech Stocks	384.55%	10.58%	-295.13%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Slate path capital lp	704.12K	8.54%	$27.44M
Vanguard group	424.82K	4.53%	$1.83M
Blackrock funding, inc. /de	391.00K	4.17%	$1.68M
American financial group	223.66K	2.39%	$961.73K
683 capital management	176.03K	2.13%	$6.77M
Vestal point capital, lp	167.00K	2.03%	$6.51M
Geode capital management	157.13K	1.68%	$675.83K
Renaissance	104.50K	1.11%	$449.35K
Invesco	82.61K	1.00%	$3.22M
Fmr	82.22K	1.00%	$3.20M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Slate path capital lp	704.12K	0.42%	$27.44M
683 capital management	176.03K	0.35%	$6.77M
American financial group	223.66K	0.35%	$961.73K
Vestal point capital, lp	167.00K	0.29%	$6.51M
Parkman healthcare partners	65.00K	0.26%	$2.53M
Duncan williams asset management	80.77K	0.08%	$311.78K
Diadema partners lp	2.19K	0.02%	$85.15K
Persistent asset partners	500.00	0.01%	$19.48K
Boothbay fund management	20.19K	0.01%	$786.76K
Farallon capital management	43.23K	0.01%	$1.68M

Top Buyers

Holder	Shares	% Assets	Change
American financial group	223.66K	0.35%	223.66K
Vestal point capital, lp	167.00K	0.29%	167.00K
Invesco	82.61K	0.00%	82.61K
Fmr	82.22K	0.00%	82.22K
Duncan williams asset management	80.77K	0.08%	80.77K

Top Sellers

Holder	Shares	% Assets	Change
Marshall wace, llp	-	-	-24.98K
Monaco asset management sam	-	-	-13.59K
Ubs group	35.55K	-	-12.92K
Nuveen	-	-	-5.95K
Charles schwab investment management	11.80K	-	-3.47K

New Positions

Holder	Shares	% Assets	Change	Value
American financial group	223.66K	0.35%	223.66K	$961.73K
Vestal point capital, lp	167.00K	0.29%	167.00K	$6.51M
Invesco	82.61K	0.00%	82.61K	$3.22M
Duncan williams asset management	80.77K	0.08%	80.77K	$311.78K
Parkman healthcare partners	65.00K	0.26%	65.00K	$2.53M

Sold Out

Holder	Change
Sound income strategies	-2.00
Trust co of toledo na /oh/	-9.00
Kiker wealth management	-13.00
Raymond james financial	-65.00
China universal asset management	-1.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	48	-28.36%	1,830,953	-29.68%	19	1.96%	33	-26.67%	4	-33.33%
Sep 30, 2025	37	-22.92%	1,220,244	-36.55%	14	3.50%	27	-43.75%	3	-
Jun 30, 2025	30	-	897,987	-	9	-	30	-	-	-

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-

TVRD Ownership FAQ

Who Owns Tvardi Therapeutics?

Tvardi Therapeutics shareholders are primarily institutional investors at 19.53%, followed by 27.53% insiders and 52.94% retail investors. The average institutional ownership in Tvardi Therapeutics's industry, Biotech Stocks , is 384.55%, which Tvardi Therapeutics falls below.

Who owns the most shares of Tvardi Therapeutics?

Tvardi Therapeutics’s largest shareholders are Slate path capital lp (704.12K shares, 8.54%), Vanguard group (424.82K shares, 4.53%), and Blackrock funding, inc. /de (391K shares, 4.17%). Together, they hold 17.24% of Tvardi Therapeutics’s total shares outstanding.

Does Blackrock own Tvardi Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Tvardi Therapeutics.

Who is Tvardi Therapeutics’s biggest shareholder by percentage of total assets invested?

Slate path capital lp is Tvardi Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.42% of its assets in 704.12K Tvardi Therapeutics shares, valued at 27.44M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools